STAT+: Prometheus raises $12 billion in capital for artificial engineers
Get the Culture newsletter
Daily culture — film, music, books, the trends and ideas worth your attention. Free.
- Prometheus raised $12 billion to build artificial‑general engineers.
- Abridge partnered with Eli Lilly to improve clinical trial recruitment.
- Abridge partnered with Nvidia to apply AI to clinical trial recruitment.
- Abridge aims to optimize clinical trial recruitment through AI.
Why it matters: The $12 billion infusion gives Prometheus the resources to pioneer advanced AI engineering, while Eli Lilly and Nvidia gain early access to AI‑driven trial efficiencies; the nonprofit’s free drug distribution directly benefits pediatric leukemia patients, bypassing traditional market pricing and reducing the financial burden on families.
